Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal contract designed to protect the intellectual property rights and provide a framework for collaboration between both parties. This agreement outlines the terms and conditions for the licensing of collateral materials developed by the University and utilized by Gentling within the state of California. Under this agreement, Gentling, Inc. is granted a non-exclusive license to use specified collateral materials, such as research findings, patents, copyrights, trademarks, and proprietary information developed by The University of North Texas Health Science Center. These materials may include but are not limited to scientific discoveries, innovations, and technologies. The California Collateral License Agreement aims to foster a cooperative working relationship between Gentling, Inc. and The University of North Texas Health Science Center, allowing the parties to mutually benefit from their respective expertise and resources. By granting this license, the University aims to encourage and facilitate the commercialization and further development of its intellectual property. The agreement outlines the rights and responsibilities of both parties when it comes to the use, protection, and disclosure of the licensed collateral materials. It specifies the duration of the license, payment terms, sublicensing provisions, confidentiality obligations, and dispute resolution mechanisms. It is important to note that there may be different types of California Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific nature of the licensed collateral materials and the intended use. For example, one agreement may focus on patent licensing, while another could pertain to trademark licensing or a combination of various intellectual property rights. In summary, the California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a legal framework to govern the licensing and utilization of collateral materials, promoting innovation, research, and commercialization while protecting the intellectual property rights of both parties.
The California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal contract designed to protect the intellectual property rights and provide a framework for collaboration between both parties. This agreement outlines the terms and conditions for the licensing of collateral materials developed by the University and utilized by Gentling within the state of California. Under this agreement, Gentling, Inc. is granted a non-exclusive license to use specified collateral materials, such as research findings, patents, copyrights, trademarks, and proprietary information developed by The University of North Texas Health Science Center. These materials may include but are not limited to scientific discoveries, innovations, and technologies. The California Collateral License Agreement aims to foster a cooperative working relationship between Gentling, Inc. and The University of North Texas Health Science Center, allowing the parties to mutually benefit from their respective expertise and resources. By granting this license, the University aims to encourage and facilitate the commercialization and further development of its intellectual property. The agreement outlines the rights and responsibilities of both parties when it comes to the use, protection, and disclosure of the licensed collateral materials. It specifies the duration of the license, payment terms, sublicensing provisions, confidentiality obligations, and dispute resolution mechanisms. It is important to note that there may be different types of California Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific nature of the licensed collateral materials and the intended use. For example, one agreement may focus on patent licensing, while another could pertain to trademark licensing or a combination of various intellectual property rights. In summary, the California Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a legal framework to govern the licensing and utilization of collateral materials, promoting innovation, research, and commercialization while protecting the intellectual property rights of both parties.